EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumour Necrosis Factor‐α Promotes Pyroptosis in Diabetic Liver Injury via the HMGB1 / TLR4 / MyD88 / NF ‐ κB Pathway

Dayin Chen, Jiajun Cheng, Bin Ni, Ruixin Zhu, Wei Wu, Minghui Zhang, Yihe Cao, Zhimei Jiang, Hongyu Sui iD

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)

DOI: 10.1111/jcmm.71220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 31.05.2026. Verfasst von Dayin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Affiliated Hospital, Jiamusi University, Jiamusi, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, HMGB1 Protein, Myeloid Differentiation Factor 88, Pyroptosis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, Northern Unique Medicinal Resources Research and Development Team, Jiamusi University Doctoral Cultivation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic liver injury (DLI) is a serious inflammatory complication, with tumour necrosis factor‐alpha (TNF‐α) recognized as a key pro‐inflammatory cytokine. This study aimed to investigate the protective effect of TNF‐α inhibition on DLI and to elucidate the underlying molecular mechanisms, focusing on the novel role of pyroptosis. An integrated experimental approach was employed, commencing with in vitro studies in HepG2 hepatocytes to dissect the signalling pathway, followed by in vivo validation in Sprague–Dawley rats. In vitro assessments included the expression of pyroptosis‐related proteins (caspase1, Gasdermin D [GSDMD]), high mobility group protein B1 (HMGB1), and components of the Toll‐like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor‐κB (NF‐κB) pathway under high glucose conditions with or without TNF‐α inhibition. In vivo measurements comprised liver function tests alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), triglycerides (TG), liver histopathology, and analysis of the HMGB1/TLR4/MyD88/NF‐κB pyroptosis axis in liver tissues. In vitro, TNF‐α inhibition mitigated high glucose‐induced hepatocyte pyroptosis and suppressed HMGB1 release and TLR4/MyD88/NF‐κB signalling; pharmacological blockade of HMGB1 replicated these effects. In vivo, recombinant human TNF receptor‐II:Fc fusion protein (rhTNFR:Fc) significantly improved liver function and histopathology in diabetic rats without affecting blood glucose levels, while also downregulating the expression of HMGB1/TLR4/MyD88/NF‐κB pathway components and key pyroptosis markers such as NOD‐like receptor family pyrin domain containing 3 (NLRP3). In conclusion, TNF‐α promotes DLI by driving hepatocyte pyroptosis through the HMGB1/TLR4/MyD88/NF‐κB signalling axis. Inhibition of TNF‐α confers potent hepatic protection independent of glycemic control, identifying it as a promising therapeutic strategy for DLI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4HMGB1 ProteinMyeloid Differentiation Factor 88PyroptosisTumor Necrosis Factor-alphaNF-kappa BDiabetes Mellitus, ExperimentalLiver DiseasesAnimalsSignal TransductionHumansRatsMaleRats, Sprague-DawleyLiverHep G2 Cells

Stichwörter der Autor:innen

HMGB1NLRP3 inflammasomeTLR4 signallingsignalingTNF‐αdiabetic liver injurypyroptosisstreptozotocin

Substanzen

Toll-Like Receptor 4HMGB1 ProteinMyeloid Differentiation Factor 88Tumor Necrosis Factor-alphaNF-kappa BTlr4 protein, ratHbp1 protein, rat

Autor:innen und Institutionen

  • Department of Urology, First Affiliated Hospital, Jiamusi University, Jiamusi, China.
  • Department of Physiology, Basic Medical College, Jiamusi University, Jiamusi, Heilongjiang, China.
  • Rehabilitation Medicine College, Jiamusi University, Jiamusi, China.

ORCID-Profile: Hongyu Sui

Förderung

  • Natural Science Foundation of Heilongjiang Province
  • Northern Unique Medicinal Resources Research and Development Team
  • Jiamusi University Doctoral Cultivation Fund
  • Training Project for Innovation and Entrepreneurship of Jiamusi University

Zitieren

APA

Chen, D., Cheng, J., Ni, B., Zhu, R., Wu, W., Zhang, M., Cao, Y., Jiang, Z., & Sui, H. (2026). Tumour Necrosis Factor‐α Promotes Pyroptosis in Diabetic Liver Injury via the HMGB1 / TLR4 / MyD88 / NF ‐ κB Pathway. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71220

Vancouver

Chen D, Cheng J, Ni B, Zhu R, Wu W, Zhang M, et al. Tumour Necrosis Factor‐α Promotes Pyroptosis in Diabetic Liver Injury via the HMGB1 / TLR4 / MyD88 / NF ‐ κB Pathway. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71220

BibTeX
@article{Chen2026,
  author = {Chen, Dayin and Cheng, Jiajun and Ni, Bin and Zhu, Ruixin and Wu, Wei and Zhang, Minghui and Cao, Yihe and Jiang, Zhimei and Sui, Hongyu},
  title = {Tumour Necrosis Factor‐α Promotes Pyroptosis in Diabetic Liver Injury via the HMGB1 / TLR4 / MyD88 / NF ‐ κB Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/jcmm.71220}
}
Kostenlos starten →